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Genomic DNA of the Towne strain human cytomegalovirus polymerase (pol) gene (4.4-kb RsrII-NcoI segment
of the EcoRI J fragment) was cloned into plasmids containing either the T3 or the T7 promoter for in vitro
transcription-translation studies. The translation efficiency of unmodified pol cRNA was poor in this system
and could not be improved by capping. However, the efficiency could be enhanced by replacing the leader
sequence with a 40-bp AT-rich sequence derived from an alfalfa mosaic virus, R4. pol cRNA directed the
synthesis of a 140-kDa polypeptide in a rabbit reticulocyte translation system. The in vitro-translated wild-type
enzyme possessed significant polymerization activity which could be stimulated by salt as could that of the
authentic enzyme purified from virus-infected cells. To study the critical domains of this enzyme, nine
mutations were introduced into the pol gene around the conserved domains of eukaryotic polymerase by
oligonucleotide-directed mutagenesis. Two constructs with mutations at amino acid residues 323 to 325
(M32QS) and 725 to 726 (M7211) remained active, with partial loss of enzyme activity, while the enzyme
activities of other mutants with alterations at four domains located around amino acid residues 729 to 730
(M73HN), 804 to 807 (M80 and DE80), 910 to 913 (M91 and DE91), and 962 to 964 (M96 and DE96) were
abolished. DNA template and triphosphate binding assays indicated that the mutation at 804 to 807 (conserved
region III) lost the ability to bind DNA template, and four mutants, M73HN (within conserved region II), M80
(in region III), M91 (in region I), and M96 (around region V [962 to 964; amino acid sequence KKR]), failed
to bind deoxyribonucleoside triphosphate. These data suggest that conserved region Ill is essential for DNA
template binding, while residues between conserved region II and V (725 to 964) are involved in triphosphate
binding.
Human cytomegalovirus (HCMV), a member of the herpes-
virus family, is a ubiquitous human pathogen associated with a
wide variety of clinical manifestations. Like other herpes group
viruses, HCMV is able to enter latency and reactivate after
primary infection. The outcome of HCMV infection often is
asymptomatic, but severe and fatal infections are frequently
encountered, in developing fetuses and immunocompromised
individuals, such as transplant recipients and patients with
AIDS (2, 13). HCMV has become a major opportunistic viral
pathogen among organ transplant recipients and patients with
AIDS. Thus, the development of anti-HCMV compounds has
become a priority in research on infectious diseases. In con-
trast to herpes simplex viruses (HSVs), HCMV does not
encode a virus-specific thymidine kinase (9). Although it
encodes a protein phosphotransferase (UL97) which is able to
weakly phosphorylate 9-(1,3-dihydroxy-2-propoxymethyl)gua-
nine (DHPG, ganciclovir) in vitro, the substrate(s) for this
enzyme in virus-infected cells is unknown (27, 32). HCMV-
specific DNA polymerase, therefore, is a prime target for
developing potent anti-HCMV compounds, and study of the
mechanism of action of this enzyme is warranted.
Purified HCMV DNA polymerase consists of two polypep-
tides of 140 and 58 kDa (29). Comparison of this enzyme with
that of HSV-1 (14, 15, 32) and with some other a-like DNA
polymerases (34) suggests that the 140 kDa peptide possesses
the core DNA polymerase activity. An accessory protein of
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HSV-1 DNA polymerase with a molecular size of 65 kDa
(UL42) was able to increase the activity and processivity of
HSV-1 polymerase (10, 14, 33). Similarly, Ertl and Powell (7)
demonstrated that the accessory protein of HCMV poly-
merase, ICP36 (UL44), was able to physically and functionally
interact with baculovirus-expressed 140-kDa core enzyme (8).
Sequence analyses of the polymerase (pol) genes of the AD169
and Towne strains ofHCMV have been done by Kouzarides et
al. (23) and our laboratory (in preparation), respectively.
Detailed comparison of the DNA sequences of the core
enzymes of both strains of HCMV with that of HSV-1 and
Epstein-Barr virus reveals that more than 24% of their se-
quences are precisely conserved (23). Structural and functional
studies of HSV-1 DNA polymerase as done previously by using
drug-resistant mutants and in vitro site-directed mutagenesis
resulted in information valuable for an understanding of the
biochemistry of the HSV-1 enzyme (5, 6, 11, 22, 30). On the
other hand, although HCMV polymerase has been expressed
in insect cells (7, 8), very limited information of a similar
nature has been obtained for HCMV. We therefore made an
attempt, using in vitro site-directed mutagenesis and in vitro
transcription-translation approaches, to uncover the essential
domains of HCMV DNA polymerase.
DNA-dependent DNA polymerases, including those from
prokaryotes, eukaryotes, and viruses, contain several enzymat-
ically active centers: (i) a DNA template binding site, (ii) a
primer binding domain, (iii) a 3'-5' exonuclease site, (iv) 5'-3'
exonuclease activity, (v) a deoxynucleoside triphosphate
(dNTP) binding site, and (vi) a DNA chain elongation domain
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FIG. 1. Schematic diagram of the location of the pol gene on the Towne strain HCMV genome and the construction of HCMVpol recombinant
plasmids pEXpol, pApol-1, and pApol for in vitro expression of the HCMV pol gene. The HCMV pol gene was located within a 9.4-kb EcoRI J
fragment of HCMV DNA. Transcription direction is indicated by arrows. Standard procedures were used to construct HCMV DNA polymerase
gene clones as described in Materials and Methods. The rationale for cloning the HCMVpol gene first in both M13mpl8 and M13mpl9 is to obtain
two orientations of pol gene constructs (left). The scheme on the right shows the procedures for inserting the full-length pol reading frame
recovered from mpl8pol into pGEM EX-1 at a position downstream of the T3 promoter (pEXpol) and into pGEM1 (from pA9) at a position
downstream of the AMV R4 leader sequence (pApol and pApol-1). In pEXpol, the HCMVpol leader sequence between EcoRI (AluI) and RsrII
was retained as in pApol-1; in pApol, this HCMV leader sequence was removed by RsrII digestion. Plasmid pA9 (18) was used to generate a
pGEM-1 vector with AMV R4 leader sequence to construct pApol-1 and pApol. In this case, pApol-1 and pApol both contain the AMV R4 leader
sequence downstream of the T7 promoter. RB, retinoblastoma cDNA.
(21). Comparison of the amino acid sequences of these ox-like
DNA polymerases shows that they share regions of striking
sequence similarity. Furthermore, these conserved regions
occur in the same sequential order within the enzyme mole-
cules (34), suggesting that they share common basic molecular
structures and that the active domains within the conserved
regions are functionally related among polymerases of various
origins. Therefore, previous studies of prokaryotic as well as
eukaryotic enzymes, particularly that of HSV-1, provide valu-
able information and guidelines for designing experiments to
study the biochemistry and active domains of HCMV-specific
DNA polymerase.
The purpose of this publication is to report the expression of
the HCMV pol gene in vitro, the effects of HCMV pol leader
sequence on RNA translation, and the identification of several
essential and active moieties of the core enzyme of HCMV
DNA polymerase via the application of site-directed mutagen-
esis and in-frame deletion mutation. In vitro transcription-
translation studies were used to analyze the effects of these
mutations on HCMV DNA polymerase activity.
MATERIALS AND METHODS
Construction of HCMV pol gene recombinants. HCMV
Towne strain (passages 36 to 40) was used in this study. The
location of the EcoRI J fragment containing the HCMV DNA
polymerase gene is shown in upper left corner of Fig. 1. M13
recombinant phages and plasmids carrying the HCMV pol
gene were constructed by standard methods and are shown on
the left side of Fig. 1. In brief, Towne strain HCMV DNA was
purified from extracellular virus as described previously (17).
An HCMV DNA genomic library was constructed in pBR322
by using EcoRI-restricted HCMV DNA fragments (2). A
9.4-kb HCMV EcoRI J fragment which contained the pol gene
was recovered from plasmid pHD10 by EcoRI digestion.
Because the 5' end of the HCMV pol gene lacks an appropri-
ate enzyme site, the intact pol DNA fragment was constructed
in two subcloning steps. The first involved 5'-half manipula-
tion. The EcoRI J fragment was digested with BglII, and the
2-kb BglII fragment containing the glycoprotein B gene and 5'
half of the pol gene was recovered and inserted into the
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M13mpl9 BamHI site to create recombinant phage M13
mpl9Bgl II. The M13 mpl9Bgl II replicative form (RF) DNA
was digested with PstI and BamHI. A 1.2-kb PstI-BamHI DNA
fragment was recovered and partially digested with AlIul to
generate a 0.74-kbAluI-BamHI DNA fragment, spanning from
positions -23 relative to the initiation codon to +719 of the
pol gene. This 0.74-kb AluI-BamHI fragment was then inserted
into M13mpl9 between the SmaI and BamHI sites. After
identification of both flanking ends by DNA sequencing, the
resultant recombinant phage was named M13 mpl9pol-1. The
M13 mpl9pol-1 RF DNA was cut with Ncol (at position +650)
and ligated to the 3.8-kb NcoI subfragment (spanning +651 to
+4422 of the pol gene), generated from NcoI digestion of the
genomic EcoRI J fragment. The orientation of insertion was
confirmed by PstI digestion and DNA sequencing. Thus, the
full HCMVpol reading frame starting from 23 bp upstream of
the initiation codon to the second poly(A) signal at the 3' end
was cloned into M13mpl9; this final recombinant was desig-
nated mpl9pol. The mpl9pol RF DNA was digested with
EcoRI and HindlIl, and the resulting 4.5-kb DNA fragment of
the pol gene was then cloned into mpl8 between the EcoRI
and HindIll sites to generate mpl8pol. In mpl9pol, the pol
DNA sequence is in the antisense direction relative to the
unique HindIll site, while in mpl8pol, it is in the sense
direction (Fig. 1, bottom left).
To express the pol gene in vitro, a recombinant plasmid,
pEXpol, carrying the pol gene under the control of the T3
RNA polymerase promoter was constructed (Fig. 1, upper
right corner). Plasmid pGEM EX-1 DNA (Pharmacia) was
digested by EcoRI and Hindlll, and the 4.5-kb EcoRI-HindIII
DNA fragment of the pol gene from mp I8pol was inserted into
pGEM EX-1 between the EcoRI and HindIll sites to yield
pEXpol. Thus, in pEXpol, the pol gene is located immediately
downstream from the T3 promoter.
The efficiency of the in vitro translation of pol cRNA made
from pEXpol DNA was very poor (see Results). We specu-
lated that the GC-rich 5' untranslated leader sequence of the
authentic HCMV pol gene retained in the pEXpol RNA
transcript might limit the translation efficiency in a rabbit
reticulocyte system or that factors other than those existing in
the reticulocyte lysate may be needed to overcome this hand-
icap. Therefore, we constructed another series of recombinant
plasmids for in vitro translation. pA9, a pGEM1 derivative with
a retinoblastoma cDNA insert (a kind gift from W. H. Lee),
contains 40 bp of high-AT alfalfa mosaic virus (AMV) R4
leader sequence downstream from the T7 promoter (18). At
the 3' end of the R4 leader sequence, there is an AhaII (Narl)
site. We subsequently used this site as the base to engineer the
HCMV pol recombinants containing R4 leader sequence.
Plasmid pA9 was partially digested with AhaII (Fig. 1, right),
filled in with Klenow enzyme to create blunt ends at both
terminals, and then digested with HindIll. The desired 2.8-kb
AhaII-HindIII DNA fragment with the T7 promoter and AMV
R4 leader sequence was recovered and used as a vector to
construct two kinds of plasmids with a difference in length of
the remaining leader sequences downstream from R4 (Fig. 1,
lower right corner). In the first construction, the mpl8pol RF
DNA was digested with RsrII and filled in with Klenow
fragment to create a blunt end before being cut with HindlIl.
The resulting 4.5-kb DNA HindlII-RsrII fragment of the pol
gene was ligated to the linearized 2.8-kb AhaII-HindIII vector
to yield the recombinant plasmid pApol. In pApol, the pol gene
was downstream from a T7 promoter, and the original 5'
noncoding leader sequence of HCMV pol was removed to
position -7 relative to the translation initiation site by RsrII
digestion and replaced with a stretch of high-AT sequences
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FIG. 2. Comparison of the in vitro translation efficiencies of
pEXpol, pApol-1, and pApol. Two micrograms each of in vitro-
synthesized cRNAs from linearized pEXpol, pApol-1, and pApol was
subjected to in vitro translation as described in the text. Translation
products were subjected to SDS-PAGE and DNA polymerase activity
assays. The plasmid arrangements of constructs are shown on the left.
Five microliters each of translation lysate was used for DNA polymer-
ization assays and SDS-PAGE analysis. The amount of Pol peptide
synthesized was measured by using the intensity of the 140-kDa
peptide obtained in each reaction and expressed as relative activity,
using the intensity of the pApol 140-kDa peptide as 1.
from the AMV R4 leader sequence (5'-GTTl7l`TTATTTTTA
ATTTTCl[T[CAAATACTTCCATCGGCGGTCCGCTATG
-3 ).
We prepared another construction, pApol-l (Fig. 1, middle
right), in which the leader sequence between All and RsrII
(5'-CTGTCAGCCTCTCACG-3', -23 to -8 from the initia-
tion codon) were preserved downstream from the AMV R4
sequence. The differences between pApol-l and pApol is that
pApol-1 has an additional 16 bases(Al/lI to RsrII) downstream
from the AMV R4 sequence (Fig. 2).
Oligonucleotide-directed mutagenesis. Oligonucleotides
were synthesized by using an Applied Biosystems DNA syn-
thesizer and purified by electrophoresis in 20% acrylamide-8
M urea gels. Full-length oligonucleotides were recovered from
gels and phosphorylated by polynucleotide kinase reaction.
The sequences of oligonucleotides used for mutagenesis are as
follows: M32QS, 5'-GCA CAC GCACGC GAT CAG AAT
GAC AAT-3'; M7211, 5'-GTG GGC CAT GAG GAG GGA
AGG GTA-3'; M73HN, 5'-GTA GCA GAG GTC GTC GGC
CAT GAT-3'; M80, 5'-TTT GAG CGC CAT CAG TAC AAT
GCC GAG CAA CAT ACG-3'; DE80, 5'-TTT GAGCGC
CAT GAGCAA CAT ACG-3'; M91, 5'-GCG GAC AAA
CAC GCG GAC CGC GCC CCC GTA GAT GAC-3'; DE91,
5'-GCG GAC AAACAC CCC GTA GAT GAC-3'; M96,
5'-ThTT GCC GAT GTA AAG TATCGA GCA GAT CAT
CAT-3'; and DE96, 5'-TTT GCC GAT GTA GCA GAT CAT
CAT-3'.
Oligonucleotide-directed mutagenesis was performed as de-
scribed by Kunkel (26). A pol DNA KpnI-HindIII fragment
(+2168 relative to the HindIll site after the second polyade-
nylation signal) was cloned into the M13mpl8 KpnI-HindIII
site to create mpl8pol K-H, in which single-stranded phage
DNA was used as a template for the mutagenesis reaction
(except for M32QS). Uracil-containing single-stranded recom-
binant phage DNA was obtained by growing the M13mpl8
recombinant phage in Escherichia coliCJ236 in the presence of
50 [tg of uridine per ml in 2x YT medium (10 g of yeast
extract, 16 g of tryptone, and 5 g of NaCl per liter) and was
used as a template for the mutagenesis reaction. To facilitate
mutation, two 5'-phosphorylated oligonucleotides, a mu-
tagenized oligonucleotide of pol sequence and an oligonucle-
otide of M13 sequence, were used together to anneal with the
VOL. 67, 1993
6342 YE AND HUANG
template. The mutagenesis and synthesis reaction was carried
out with Klenow fragment at 16°C overnight in the presence of
the four dNTPs (200,uM each) and T4 DNA ligase (1 U per
reaction). The end product of this reaction was extracted with
phenol-chloroform and used to transform E. coli JM107 com-
petent cells. The recombinant mutants were screened, and
DNA sequences were confirmed by DNA sequence analysis by
the dideoxy-chain termination method. The pol DNA frag-
ments with the correct mutations were isolated and used to
construct the pGEM series of plasmids for in vitro transcrip-
tion.
In vitro transcription and translation. Wild-type and mu-
tant plasmids, both pEXpol and pApol cloned in pGEM
vectors, were linearized with HindlIl. Linearized DNAs were
purified by low-melting-point agarose gel electrophoresis.
DNAs were recovered from the gel, extracted with phenol-
chloroform, and then precipitated with ethanol. In vitro tran-
scription was carried out by using T7 RNA polymerase for the
pApol DNA template and with T3 RNA polymerase for
pEXpol constructs. For uncapped transcription, the reaction
mixture contained 10 [LI of 5 x transcription buffer (40 mM
Tris-HCl [pH 7.9], 6 mM MgCl2, 2 mM spermidine), 2 jig of
linearized DNA, 2.5,lI (10 mM each) of ATP, GTP, CTP, and
UTP, 50 U of RNasin, 5 RI of 100 mM dithiothreitol, 5 jil of
10-mg/ml bovine serum albumin, and 50 U of RNA poly-
merase; the final volume was made up to 50 pI with distilled
H20. The reaction mixture was incubated at 37°C for 1 h. The
template DNA was digested with DNase I at 37°C for 15 min.
For capped transcription, 5 pI of 10mMm7GpppG was added
to the reaction mixture and the final concentration of GTP was
reduced to 50 ,uM. The synthesized RNA was purified by
phenol extraction and ethanol precipitation in the presence of
1 M ammonium acetate and then dissolved in diethyl pyrocar-
bonate-treated H20. The purified RNA was sized and quanti-
tated on 1.2% agarose-formaldehyde gels. Four microliters of
RNA ladders with sizes ranging from 0.24 to 0.95 kb (1 jig/pA)
was applied in parallel for size measurement by gel electro-
phoresis.
The RNA was translated in 50 [lI of reaction mixture
composed of 10 jiCi of [35S]methionine, 2 jg of RNA, and 35
plI of reticulocyte lysate (Promega Biotec) at 30°C for 60 min as
instructed by the supplier. Aliquots were then taken for DNA
polymerase activity assay and for protein analysis by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). Prestained protein molecular weight markers (Bio-
Rad, Richmond, Calif.) were used for size measurement.
DNA polymerase assay. DNA polymerase activity assays
were carried out as described previously (29). In brief, the
reaction mixture, in a 50-pA volume, contained 50 mM Tris-
HCl (pH 8.0), 70 mM ammonium sulfate, 10 mM MgCl2, 5 jig
of activated calf thymus DNA, 10 jiM each dGTP, dYTP, and
dCTP, 2.0 ,uCi of [cx-32P]dATP (3,000 Ci/mmol; New England
Nuclear), and 5 jil of translation product. Polymerase reaction
mixtures were incubated at 37°C for 30 min. The reaction was
stopped by the addition of 100 jil of 20% ice-cold trichloro-
acetic acid containing 0.4% acid hydrolyzed yeast RNA and
0.02 M sodium pyrophosphate, set in ice for 15 min, and then
filtered onto a Whatman GF glass filter. Filters were washed
five times with 5 ml of 5% trichloroacetic acid. Acid-precipi-
table radioactivity was measured by liquid scintillation count-
ing. Three samples from each transcription-translation reac-
tion were assayed for enzyme activities.
DNA template and deoxyribonucleoside triphosphate bind-
ing assays. For the DNA template binding assay, purified
pRc/RSV plasmid DNA (5.2 kb; Invitrogen, San Diego, Calif.)
was linearized by HindIll digestion and nicked with pancreatic
DNaseI (10-4 U/100,ug/ml; at room temperature for 15 min,
followed by heat inactivation at 70°C for 15 min). The nicked
pRc/RSV DNA was used as the template for detecting the
ability of the enzyme to bind DNA template. Ten microliters of
[35S]methionine-labeled DNA polymerase and 10,ug of nicked
DNA template were mixed in polymerase assay buffer and kept
in ice for 30 min. The reaction mixture was then loaded onto a
5-ml 10 to 50% (wt/vol) sucrose gradient and centrifuged for
3.5 h at 46,000 rpm in a Beckman SW50.1 rotor. Fractions
were collected from the bottom, and the radioactivity in each
fraction was measured.
For the deoxyribonucleoside triphosphate binding assay, the
cold in vitro-translated polymerase, wild type or mutant, was
mixed with 1 RCi of [a-32P]dATP in 40 RI of polymerase
reaction buffer and incubated at 37°C for 30 min. The reaction
mixture was then loaded onto a 5-ml 10 to 30% (wt/vol)
sucrose gradient. After centrifugation in a Beckman SW50.1
rotor for 15 h at 46,000 rpm at 4°C, fractions were collected
from the bottom of the tube, and the radioactivity in each
fraction was measured.
RESULTS
Construction of HCMV pol templates and in vitro expres-
sion. The 4.5-kb HCMV DNA fragment containing the com-
plete HCMV pol gene coding region and two polyadenylation
signal sequences at the 3' end was cloned into M13mpl8,
M13mpl9, and pGEM EX-1. The resultant constructs,
mpl8pol, mpl9pol, and pEXpol, respectively, each retained
the original 23-bp GC-rich noncoding leader sequence up-
stream of the initiation codon. In pEXpol, the pol gene was
downstream from the T3 promoter. After linearization by
HindIll, the pEXpol DNA as well as all nine mutated pEXpol
DNAs were transcribed in vitro with T3 RNA polymerase
under the conditions for capping as well as uncapping. They all
yielded almost the same quantity of 4.5-kb RNA products. No
distinguishable difference in size among the transcription
products of wild-type pEXpol and mutated pol genes was
found when the products were sized and quantitated on
agarose-formaldehyde gels (data not shown). The size of the
4.5-kb RNA product corresponds with the predicted size of the
wild-type pol DNA transcript. The purified RNAs were sub-
jected to in vitro translation using rabbit reticulocyte lysate in
the presence of [35S]methionine. The translation mixtures were
assayed directly for enzymatic activity and were subjected to
protein analysis by SDS-PAGE. Very little polymerase activity
was found in the translation mixtures, including RNAs from
wild-type and nine mutated pol gene constructs, both capped
and uncapped. Also, no detectable polypeptide with a molec-
ular size of 140 kDa, like that of native HCMV DNA poly-
merase core enzyme, was observed when the reaction products
were subjected to SDS-PAGE. On the other hand, the control
brome mosaic virus RNA, provided with the kit, translated
very well under similar conditions.
The linearized pApol-1, pApol, and nine mutated pol gene
plasmids (pApol mutants), all with AMV R4 leader sequence,
were then transcribed in vitro with T7 RNA polymerase. The
in vitro transcription efficiency for all constructs indicated
above did not show significant variation. On the other hand, as
shown in Fig. 2, a significant difference in translation was
observed between pApol and pApol-1.
In vitro-transcribed RNAs from pApol and pApol mutants
were then translated in rabbit reticulocyte lysate as described
above. The major translation product from the wild type and
mutants has a molecular size of 140 kDa in SDS-PAGE, a size
corresponding with that of the core enzyme purified from
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FIG. 3. SDS-PAGE analysis of in vitro translation products of
wild-type HCMV pol and its mutants. Two micrograms of wild-type
(WT) or mutant pol cRNA was translated in rabbit reticulocyte lysate
in the presence of [35S]methionine; 5 RI of each translation mixture
was analyzed by SDS-PAGE (10% polyacrylamide gel). The arrow
indicates the 140-kDa Pol peptide. Molecular weight markers are
shown in kilodaltons on the left. Panels A and B represent two
separate experiments.
HCMV-infected cells (29) and with the predicted size of the
HCMVpol open reading frame (Fig. 3). The relative yields of
140-kDa translation product from the wild type and the
mutants are almost identical. To determine the enzyme activity
of the 140-kDa polypeptide synthesized in the programmed
translation mixtures, each reaction mixture was directly as-
sayed for enzymatic activity in the presence of 0.07 M ammo-
nium sulfate. Relatively high DNA polymerase activity from
wild-type pApol was detected in the reticulocyte reaction
mixtures. This enzyme activity could be stimulated approxi-
mately onefold by the addition of 35 to 70 mM ammonium
sulfate compared with the level without ammonium sulfate.
This characteristic is similar to that of the authentic HCMV
DNA polymerase extracted from virus-infected HEL cells
reported previously (16, 29).
Site-directed mutation of the HCMV pol gene and its effects
on enzymatic activity. Oligonucleotide-directed mutagenesis
and the in vitro transcription-translation system provide a
direct approach to study the functional domains of HCMV
polymerase. Nine pol mutations, either point or deletion
mutations, were introduced into the HCMV pol gene around
regions homologous to five conserved regions of eukaryotic
polymerase. The nucleotide sequences and amino acid alter-
ations for each mutation are summarized in Fig. 4A. Three of
them (DE80, DE91, and DE96) are in-frame deletion mutants
with deletions of three to four amino acid residues. DE91
contains a deletion of four amino acid residues, 910 to 913
(DTDS), in the most conserved regions among the a-like DNA
polymerase family (region I; Fig. 4B). In M91, these acidic
DTDS residues (residues 910 to 913, deleted in DE91) were
changed into the more hydrophobic and basic GAVR. DE80
contains a deletion of residues 804 to 807 (DKEQ) within
conserved region III. In M80, charged moiety DKEQ was
changed to the more hydrophobic and noncharged GIVL.
DE96 contains a deletion of charged residues 962 to 964
(KKR) around conserved region V. In M96, the charged
sequence KKR was changed to hydrophobic noncharged SIL.
The other three mutants (M32QS, M7211, and M73HN)
contain site mutations which result in alterations of two amino
acid residues each. In M32QS, residues Q and S at positions
323 and 325 are changed to hydrophobic L and A, respectively.
In M7211, two I residues at 725 and 726 are changed to two L
residues. Mutant M73HN contains two altered residues at 729
and 730, in which the H and N residues are changed to acidic
DD. Both M7211 and M73HN contain mutations within one
long stretch of conserved region II of the DNA polymerase of
the herpesvirus family.
All nine mutated pol genes were expressed in vitro along
with the wild type, and programmed translation mixtures were
assayed to determine the effects of these mutations on enzyme
activity (Fig. 3 and 4B). The levels of synthesis of the 140-kDa
polypeptide, which represent HCMV pol, in all translation
reactions were nearly equal, as estimated by radioautograms of
intensity (Fig. 3). This finding implies that these mutations did
not affect pol gene peptide synthesis in in vitro transcription
and translation in pGEM and reticulocyte systems, respec-
tively. Two mutants, M32QS and M7211, retained one-half to
one-third, respectively, of the wild-type enzyme activity (Fig.
4B). Modification of both isoleucine residues at 725 and 726
(M7211, in region II) to leucines resulted in only a 40%
decrease in enzyme activity, while almost all of the enzyme
activity was abolished when H and N residues at 729 and 730
(M73HN) were changed to acidic DD. The other six constructs
(DE80, DE91, DE96, M80, M91, and M96) lost nearly all
enzyme activity. These data suggest that conserved regions I,
II, III, and V are essential domains for HCMV polymerase
activity. Mutagenesis study of conserved region VI was not
included in this first-phase investigation because it has a low
level of homology with that of HSV-I polymerase (6 of 17
amino acid residues).
DNA template and triphosphate binding ability. We used
sucrose gradient sedimentation analysis to study the abilities of
the in vitro-translated wild-type and mutated HCMV poly-
merases to bind DNA template and deoxyribonucleoside
triphosphate. Figure 5A shows the results of DNA template
binding assays of wild-type and mutated enzymes. In this study,
[35S]methionine-labeled enzyme was mixed with nicked and
linearized plasmid DNA molecules. A specific radioactive peak
containing plasmid DNA and polymerase complexes was found
around fraction 6 (from fractions 5 to 8) of a sucrose gradient
of the wild-type enzyme. This radioactive peak could be
abolished by the addition of an excessive amount of nonlabeled
wild-type enzyme (not shown). Similar peaks appeared in
sucrose gradients of other mutants except that of M80. This
result indicates that among the mutations studied, only the
deletion or mutation at amino acid residues 804 to 807 (with
the change from DKEQ to GIVL) results in the loss of
template binding ability. Controls, including (i) reticulocyte
lysate with DNA template and (ii) wild-type enzyme without
the addition of DNA template, did not produce a sedimenta-
tion peak like that of the wild-type polymerase.
Figure SB shows the results of the triphosphate binding
assay. In this study, the cold in vitro-translated wild-type or
mutant DNA polymerase was mixed with [x-32P]dATP and
subsequently subjected to sucrose gradient centrifugation. The
wild type and two mutants (M32QS and M7211) were able to
bind [32P]dATP and exhibited a radioactive peak around
fraction 7 of each gradient, while the remaining four mutants
(M73HN, M80, M91, and M96) did not show this ability. This
result suggests that domains around residues 729 to 730 (HN),
804 to 807 (DKEQ), 910 to 913 (DTDS), and 962 to 964
(KKR) of HCMV DNA polymerase are critical for triphos-
phate binding. The reticulocyte translation control did not give
this specific radioactive peak in the sucrose gradient.
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952 9g9
WT: 5'- GAT GAC ATT GTC ATT CAG ATC TCG TGC GTG TGC TAC GAG ACG GGA GGA- 3'
318 Q323 s I'5 _3
M32QS: CTG GCG
2158 j A 2202
WT: 5'-AGC CTC TAC CCT TCC ATC ATC ATG GCC CAC AAC CTC TGC TAC TCC -3
720 17s 1 r 734
M7211: CTC CTC
L 725 L 726
2170 2217
WT: 5-TCC ATC ATC ATG GCC CAC AAC CTC TGC TAC TCC ACCTG TTG GTG CCG -3'
724 Hr29 N 739
M73HN: GAC GACD729 D 750
2395 2442
WT: 5- CGT CGT ATG TTG CTC GAC AAG GAA CAG ATG GCG CTC AAA GTA ACG TGC - 3'
799 8o14DW4 K E Q 8C7
DE 80: delete >
GGC ATT GTA CTG
M 80: G804 V LOW
2713 2760
WT: 5'- CGG GTC ATC TAC GGG GAC ACG GAC AGC GTG TTT GTC CGC TTT CGT GGT - 3'
905 D 910T D S 913 920
DE 91: delete >
GGC GCG GTC CGC




WT: 5'- CTT ATG ATG ATC TGC AAG AAA CGT TAC ATC GGC AAA GTG GAG GGC GCC -3'
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FIG. 4. Summary of nucleotide sequences and amino acid alterations in various HCMV pol gene mutants (A) and mutation and deletion
analyses of the HCMV DNA polymerase gene (B). A schematic diagram of amino acid (AA) residues 1 to 1242 is shown at the top of panel B.
Sites of mutations (in M32QS, M721I, M73HN, M80, M91, and M96) and deletions (in DE80, DE91, and DE96) are indicated by solid bars and
broken lines, respectively. The six conserved regions defined by Wong et al. (34) and their locations relative to the HCMV Pol peptide are
presented at the bottom of panel B. DNA polymerization activities of in vitro expressed peptides are summarized at the right, expressed as
picomoles of [32P]dAMP incorporated into acid-insoluble material in 30 min at 37°C.
DISCUSSION
Many eukaryotic genes have noncoding regions of various
lengths located upstream of the translation initiation codon
(24). These 5' untranslated leader sequences play very impor-
tant roles in the rate limiting as well as the efficiency of
translation both in vivo and in vitro (25). The molecular basis
of the role of 5' untranslated sequences in regulating mRNA
translation is not well understood. Jobling and Gehrke (19)
found that the composition of the untranslated sequence had a
marked effect on the quantity of protein synthesized. This
sequence can be replaced by a heterologous leader sequence to
increase expression without changing the antigenic or biolog-
ical properties of the encoded protein (18). In this study, the
translation level of RNA from pApol deleted of the high-GC
leader sequence was about six to eight times higher than that
of the RNA from pApol-1 with the authentic high-GC leader
sequence, as estimated by enzyme activity in translation mix-
tures and by the autoradiographic intensity of the 140-kDa Pol
peptide from each translation. This result suggests that an
AT-rich composition in the untranslated leader sequences is
essential for maximal activity in HCMV pol RNA translation.
It also implies that the GC-rich region in the leader sequence
which was deleted in pApol inhibits pol RNA translation. The
translation efficiency may relate to the secondary structure or
high GC content of the untranslated leader rather than the
unique nucleotide sequence in this case. The formation of
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FIG. 5. DNA template and deoxyribonucleoside triphosphate binding analysis of HCMV polymerase mutants. (A) DNA template binding
assay. Ten micrograms of linearized and nicked pRc/RSV DNA and 10 p.l of [35S]methionine-labeled DNA polymerase were mixed in polymerase
assay buffer, kept in ice for 30 min, and subjected to 10 to 50% (wt/vol) sucrose gradient centrifugation at 46,000 rpm for 3.5 h at 4°C in a Beckman
SW50.1 rotor. Fractions were collected from the bottom of the tube for the measurement of [35S]methionine radioactivity. Controls include
reticulocyte lysate with DNA template (Cl) and wild-type (WT) enzyme without the addition of DNA template (C2). (B) dATP binding assay. Ten
microliters of in vitro-translated unlabeled polymerase was mixed with 1 p.Ci of [a-32P]dATP in 40 ,ul of polymerase reaction buffer, incubated at
37°C for 30 min, and subjected to 10 to 30% sucrose gradient centrifugation in a Beckman SW50.1 rotor for 15 h at 46,000 rpm at 4°C. Fractions
were collected from the bottom of the tube for measurement of 32P radioactivity. The translated product from reticulocyte lysate without addition
of pOI cRNA was used as the control (C).
hairpin structures by GC-rich sequences within the leader or
between the leader and other regions may inhibit the initiation
of translation (25). Other unique factor binding domains
within leader sequences, such as sequences for cap-binding
protein or ribosome recognition and binding, as well as a
domain for the binding of immediate-early gene products,
could contribute to the regulation of translation (31).
In HCMV-infected HEL cells, pol RNA can be detected as
early as 5 h postinfection, but viral DNA replication does not
reach the peak level until 72 h postinfection. This can be
attributed to the low-level expression of the HCMV DNA
polymerase gene early in the infection. The effect of the 5'
leader of pol RNA on translation may be one of the factors
responsible for the low-level expression of DNA polymerase
activity at earlier times. A similar result was found in the study
of translational regulation of HSV pol. Yager et al. (35)
demonstrated that expression of the HSV DNA polymerase
gene in vivo was regulated at the stage of translation. The HSV
pol mRNAs were relatively abundant in the cytoplasm of
infected cells at 6 h postinfection. However, only a small
fraction of mRNAs were associated with large polysomes.
Comparison of the synthesis of this Pol protein with that of
another HSV delayed-early polypeptide, thymidine kinase,
shows that the molar ratio of thymidine kinase and Pol
polypeptide synthesis per transcript is greater than 18:1 (35). A
144-base GC-rich leader sequence with the hairpin structure
encompassing the HSV pol initiation codon has been impli-
cated as causing this low efficiency of HSVpol translation at an
early stage of infection.
HCMV DNA polymerase shares conservative functional
domains with a group of eukaryotic DNA polymerases. On the
basis of amino acid sequence homology, Wong et al. (34)
identified six highly conserved regions among phage, viral, and
eukaryotic DNA polymerases. In HCMV DNA polymerase,
these conserved regions are located within amino acid residues
379 to 1100. The major DNA polymerization domains of the
HCMV enzyme could be within the region between residues
710 and 1100. This region contains highly charged amino acid
residues, such as Glu, Asp, Asn, Arg, and Lys, and sulfur-
containing Cys and heterocyclic His that are needed to interact
with DNA, substrate, Mg2+, and other proteins or subunits of
DNA polymerase. In fact, all mutations that tend to lose
enzyme activity fall within this region.
Mutant M73HN contains two substituted residues (from HN
to DD) in conserved region II. It shows a lack of DNA
polymerization activity as measured in our assay conditions.
Results from DNA template and triphosphate binding studies
indicated that mutant M73HN retained the ability to bind
DNA template, but its triphosphate binding ability was lost.
This region is located within the largest stretch of conserved
region II of the herpesvirus family, and the N residue is one of
the most conserved amino acid residues within this region. In
contrast to M73HN, mutant M7211, containing two substituted
residues (from II to LL), was only partially affected by the
II-to-LL alteration. This can be explained by the minor alter-
ation in the hydrophobic region; amino acid residues of the
same nature might not significantly affect the enzyme activity.
On the other hand, the mutation identified as a single residue
change at 719 and 724 in region II of HSV-1 pol led to the

















































6346 YE AND HUANG
tic acid (11, 22). This result implies that this domain may be
directly or indirectly involved in the recognition of substrate
binding and that the specific amino acid residue for this
function is critical. With respect to the functional domain in
region III, mutation of this region with an in-frame deletion or
alteration in residues DKEQ to GIVL (804 to 807), such as
DE80 and M80, destroyed almost all enzyme activity in an in
vitro assay. DNA template binding studies showed that mutant
M80 lost its ability to bind nicked DNA template (Fig. 5A), as
did mutant D80 (data not shown), while the remaining mutants
still possessed template binding ability. In the triphosphate
binding assay, we also failed to detect the ability of M80
enzyme to bind triphosphate. One of the characteristics of
conserved region III which distinguishes it from other con-
served regions is that most of the highly conserved residues are
basic or amide-containing amino acids, such as Q, K, and N. It
is possible that region III is involved in DNA template binding
via the interaction of charged moieties with DNA template. In
the case of the HSV enzyme, a cluster of mutations in
conserved region III (at residues 813, 815, 821, and 842)
developed resistance to deoxyribonucleoside triphosphate an-
alogs (11, 12). This region also contains Q-, N-, R-, K-, and
C-rich segments. It is therefore postulated that this region is
involved in the interactions with both DNA and triphosphate
substrates. Aspartate and glutamate residues are directly in-
volved in the binding of metallic ions. Metal ions (Mg2+,
Mn2+, and Zn2+) have been show to be critical for substrate
binding by a direct interaction with the phosphodiester bond
(1, 4). The amino acid DKEQ domain deleted in mutant DE80
may also be involved in the hydrolysis of the phosphodiester
bond of the dNTP (1, 4).
DE91 and M91 have deleted and mutated DTDS domains,
respectively, within the most conserved region I of eukaryotic
a-like DNA polymerase. M91 was able to bind DNA template
but unable to bind the substrate dATP. Delurue et al. (3)
suggested that region I located in a loop at the end of a
hairpin and an Asp residue interact with Mg2+ to form part of
an NTP binding site. Site-specific mutations in HSV-1 Pol and
human adenovirus type 2 DNA polymerase in the highly
conserved region I have been studied extensively by Dorsky
and Crumpacker (6) and Joung et al. (20), respectively. Their
results indicated that each of residues GDTD within this
region was essential for enzyme function. Mutants G885R,
D886N, T887K, and D888A of HSV-1 pol lacked polymeriza-
tion activity and failed to be stimulated by the 65-kDa DNA-
binding protein. However, another mutant (S889A) within this
region had decreased but detectable enzyme activity, and its
activity was able to be stimulated by the presence of the
65-kDa DNA-binding protein (6). In case of adenovirus type 2
polymerase, the change from S1015A in region I was also
associated with a decreased but still detectable level of enzyme
activity when measured by a pol DNA-binding protein assay
(20). Recently, Marcy et al. (30) demonstrated that mutations
in HSV Pol region I, F891C, F891Y, and V892M, exhibited
drug resistance to phosphonoacetic acid and acyclovir and
hypersensitivity to aphidicolin. These results implied that the
GDTDS domain within region I contributed directly to the
formation of a substrate dNTP recognition and binding site.
Another in-frame deletion mutant (DE96) or point mutant
(M96), at positions 962, 963, and 964 within conserved region
V (residues 971 to 988), containing three deleted or changed
amino acid residues (KKR to SIL) also lost almost all enzy-
matic activity. The results from DNA template and triphos-
phate binding assays indicated that these mutants possessed
DNA binding activity but failed to bind dATP.
Among these six groups of mutation constructs, four,
M73HN, M80, M91, and M96, were unable to bind to dNTP
substrate. This finding suggests that amino acid domains
contributing to triphosphate binding are not confined to one
region but are distributed throughout the central and C-termi-
nal portions of the peptide. This observation is further sup-
ported by the fact that a series of HSV mutants that were
resistant or hypersensitive to nucleoside analogs have been
mapped throughout regions I, II, III, V, and VI. More recently,
HCMV mutants resistant to ganciclovir, HPMPA {(S)-1[(3-
hydroxy-2-phosphonylmethyl)propyl]adenine}, and HPMPC
{(S)-1 [(3-hydroxy-2-phosphonylmethyl)propyl]cytosine} and
hypersensitive to thymidine arabinoside were mapped at con-
served region IV on the N-terminal side of the molecule (28).
It is possible that amino acid domains of these mutations are
also involved in recognition and binding of NTP or in deter-
mination of the tertiary structure of the binding site.
It is virtually impossible to delete or change a residue
without any change in protein structure and hydrophilicity.
However, two-dimensional structure analysis by computer
reveals that these mutants have not changed drastically the
structure and hydrophilic nature of the Pol peptide beyond the
mutated regions. We are not able to perform detailed three-
dimensional structure analysis of protein by computer methods
at the present time. Therefore, to further define the functions
of these conserved regions, it is essential for us to express and
purify various mutated Pol proteins for functional assay under
a variety of conditions, including the presence of other proteins
associated with the DNA replication complex.
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